The results demonstrated that serum and bronchoalveolar lavage fluid IL-6 and serum IL-8 were higher in lung cancer patients compared to non-cancer controls, suggesting that lung cancer itself upregulates the production of IL-6 and IL-8 and that the action of RT further increases BALF IL-6. The gene discussed is CXCL8; the disease is cancer.